Abiopharma

🔍 Mullen Mark (Director)

Company: Optimum Communications, Inc. (OPTU)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Sold 58,000 shares of Class A common stock (Direct)
  Date: 2026-05-29 | Code: D | equity_swap_involved: 0 | shares_owned_after: 105,697.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: On May 29, 2026, Mr. Mullen agreed to contribute 58,000 shares of Class A common stock of the Issuer to CSC Investments II LLC ("CSC"), a wholly-owned subsidiary of the Issuer, in exchange for 145 Preferred Units in CSC. The exchange was approved in advance by the Board of Directors of the Issuer pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934.